TJ, M., CL, L., MCW, W., TZ, I., TH, B., M, D., . . . IM, S. (2026). Tumor Infiltrating Lymphocyte Therapy Combined With PD-1/LAG-3 Inhibition in Patients With Recurrent Platinum-Resistant Ovarian Cancer. International journal of cancer, 159(7), 1735. https://doi.org/10.1002/ijc.70510
Chicago Style (17th ed.) CitationTJ, Monberg, et al. "Tumor Infiltrating Lymphocyte Therapy Combined With PD-1/LAG-3 Inhibition in Patients With Recurrent Platinum-Resistant Ovarian Cancer." International Journal of Cancer 159, no. 7 (2026): 1735. https://doi.org/10.1002/ijc.70510.
MLA (9th ed.) CitationTJ, Monberg, et al. "Tumor Infiltrating Lymphocyte Therapy Combined With PD-1/LAG-3 Inhibition in Patients With Recurrent Platinum-Resistant Ovarian Cancer." International Journal of Cancer, vol. 159, no. 7, 2026, p. 1735, https://doi.org/10.1002/ijc.70510.